Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
| ▸ | SCN4A | P35499 | 9/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | SCN1A | P35498 | 2/20 | 0.41 |
| ▸ | SCN5A | Q14524 | 2/20 | 0.41 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.41 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.41 |
| ▸ | KCNK2 | O95069 | 1/20 | 0.41 |
| ▸ | GBA1 | P04062 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14985358 | 0.85 | KDM4E (0.49) | CYP1A2CYP2A6TSHRACHESCN4A | |
| SCHEMBL11678596 | 0.78 | ALDH1A1 (0.54) | CYP1A2TSHRLMNACYP2C9ALDH1A1 | |
| SCHEMBL9548012 | 0.77 | CYP1A2 (0.43) | CYP1A2CYP2A6TSHRACHESCN4A | |
| SCHEMBL437049 | 0.75 | HSP90AA1 (0.50) | CYP1A2CYP2A6TSHRACHESCN4A | |
| Acetic Acid SCHEMBL16005821 | 0.75 | KMT2A (0.50) | CYP1A2TSHRLMNACYP2D6ALDH1A1 | |
| Phosphine SCHEMBL21753753 | 0.73 | HSP90AA1 (0.48) | CYP1A2CYP2A6TSHRACHESCN4A | |
| SCHEMBL145464 | 0.73 | ALDH1A1 (0.48) | CYP1A2CYP2A6TSHRACHESCN4A | |
| SCHEMBL30686934 | 0.71 | CYP1A2 (0.43) | CYP1A2CYP2A6TSHRACHESCN4A | |
| SCHEMBL4821766 | 0.71 | CYP1A2 (0.43) | CYP1A2CYP2A6TSHRACHESCN4A | |
| SCHEMBL1046570 | 0.71 | CYP1A2 (0.43) | CYP1A2CYP2A6TSHRACHESCN4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4734912-A2 | HIGH SEPARATION DUAL PHASE EYE MAKE-UP REMOVER | Mary Kay, Inc. (US) | 2026-05-06 | — | — | EP | disclosed |
| WO-2026087386-A1 | ROSIN DIESTER COMPOUNDS AND USES THEREOF | FIRMENICH SA (CH) | 2026-04-30 | — | — | WO | disclosed |
| US-20260090980-A1 | COSMETIC COMPOSITIONS AND METHODS OF USING THE SAME | MARY KAY INC. (US) | 2026-04-02 | — | — | US | disclosed |
| US-20260083659-A1 | SUNSCREEN COMPOSITIONS AND METHODS OF USE | MARY KAY INC. (US) | 2026-03-26 | — | — | US | disclosed |
| WO-2025264660-A1 | COSMETIC COMPOSITION COMPRISING CAFFEINE AND MELATONIN | MARY KAY INC. (US) | 2025-12-26 | — | — | WO | disclosed |
| US-20250387310-A1 | COMPOSITIONS THAT ENHANCE THE COOLING EFFECT | FIRMENICH INCORPORATED (US) | 2025-12-25 | — | — | US | disclosed |
| US-20250381117-A1 | COSMETIC COMPOSITION COMPRISING CAFFEINE AND MELATONIN | MARY KAY INC. (US) | 2025-12-18 | — | — | US | disclosed |
| WO-2025202256-A1 | COOLING COMPOSITION | FIRMENICH SA (CH) | 2025-10-02 | — | — | WO | disclosed |
| EP-4593967-A2 | COSMETIC COMPOSITIONS AND METHODS OF USING THE SAME | Mary Kay, Inc. (US) | 2025-08-06 | — | — | EP | disclosed |
| EP-4583718-A1 | FLAVONOID COMPOSITIONS AND USES THEREOF | Firmenich SA (CH) | 2025-07-16 | — | — | EP | disclosed |
| EP-1889850-B1 | NOVEL TRITERPENIC ACID DERIVATIVE AND PREPARATION FOR EXTERNAL APPLICATION FOR SKIN COMPRISING THE SAME | POLA CHEM IND INC (JP) | 2014-03-05 | — | — | EP | disclosed |
| CN-101166510-B | External preparation for skin | SBI ALAPROMO CO LTD | 2012-03-07 | — | — | CN | disclosed |
| US-20110060042-A1 | EXTERNAL PREPARATION FOR SKIN | SBI ALAPROMO CO., LTD. (JP) | 2011-03-10 | — | — | US | disclosed |
| US-7718635-B2 | Triterpenic acid derivative and preparation for external application for skin comprising the same | POLA CHEMICAL INDUSTRIES INC. (JP) | 2010-05-18 | — | — | US | disclosed |
| US-20090130227-A1 | EXTERNAL PREPARATION FOR SKIN | SBI ALAPROMO CO., LTD. (JP) | 2009-05-21 | — | — | US | disclosed |
| US-20090075946-A1 | NOVEL TRITERPENIC ACID DERIVATIVE AND PREPARATION FOR EXTERNAL APPLICATION FOR SKIN COMPRISING THE SAME | POLA CHEMICAL INDUSTRIES INC. (JP) | 2009-03-19 | — | — | US | disclosed |
| CN-101166510-A | External preparation for skin | COSMO OIL CO LTD (JP) | 2008-04-23 | — | — | CN | disclosed |
| EP-1889850-A1 | NOVEL TRITERPENIC ACID DERIVATIVE AND PREPARATION FOR EXTERNAL APPLICATION FOR SKIN COMPRISING THE SAME | Pola Chemical Industries Inc. (JP) | 2008-02-20 | — | — | EP | disclosed |
| EP-1878421-A1 | EXTERNAL PREPARATION FOR SKIN | COSMO OIL CO., LTD (JP) | 2008-01-16 | — | — | EP | disclosed |
| US-3931340-A | Chlorination of aromatic compounds | ASAHI DENKA KOGYO K.K. (JA) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260090980-A1 | COSMETIC COMPOSITIONS AND METHODS OF USING THE SAME | CUTA, DSG1, HIRA | CYP1A2 706/4885CYP2A6 3463/4885TSHR 3804/4885 |
| US-20250387310-A1 | COMPOSITIONS THAT ENHANCE THE COOLING EFFECT | TAS2R30, TAS2R1, TAS2R20 | CYP1A2 1058/4885CYP2A6 515/4885TSHR 4612/4885 |
| US-20090075946-A1 | NOVEL TRITERPENIC ACID DERIVATIVE AND PREPARATION FOR EXTERNAL APPLICATION FOR SKIN COMPRISING THE SAME | DUSP4, CUTA, DUSP22 | CYP1A2 2457/4885CYP2A6 1608/4885TSHR 2815/4885 |
| US-20260083659-A1 | SUNSCREEN COMPOSITIONS AND METHODS OF USE | CUTA, TYR, SUN2 | CYP1A2 144/4885CYP2A6 1216/4885TSHR 2955/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.